T. Rowe Price Associates, Inc. 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 12:24 pm Sale |
2020-12-31 | 13G | Orchard Therapeutics plc ORTX |
T. Rowe Price Associates, Inc. | 135,084 1.300% |
-411,862 (-75.30%) |
Filing |